Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity
To access this article, please choose from the options below
PII: S0145-2126(02)00002-4
© 2002 Elsevier Science Ltd. All rights reserved.
